MORTALITY IN PATIENTS WITH ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS), A SYSTEMATIC LITERATURE REVIEW (SLR)

被引：0
|
作者：
Busch, K.
Memmott, H.
McLaughlin, H.
Harrington, A.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P165
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [41] BENEFITS AND CHALLENGES OF DIFFERENT QUALITATIVE APPROACHES IN RARE DISEASE: A CASE STUDY IN ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) USING A NARRATIVE EXERCISE AND QUALITATIVE INTERVIEWS
    Skrobanski, H.
    Matter, E.
    Acaster, S.
    Hitchcock, I
    Whalen, J. D.
    Nolthenius, Tutein J.
    Crocker-Buque, A.
    Harrington, A.
    Vandenberghe, D.
    Munro, E.
    Williams, K.
    VALUE IN HEALTH, 2023, 26 (12) : S454 - S454
  • [42] Deconvolution of bulk RNA sequencing in activated phosphoinositide 3-kinase δ syndrome
    Huang, Xia
    Gu, Haiyan
    CLINICAL RESPIRATORY JOURNAL, 2023, 17 (11): : 1190 - 1195
  • [43] Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome
    Rae, William
    Ramakrishnan, Kesava A.
    Gao, Yifang
    Ashton-Key, Margaret
    Pengelly, Reuben J.
    Patel, Sanjay V.
    Ennis, Sarah
    Williams, Anthony P.
    Faust, Saul N.
    CLINICAL IMMUNOLOGY, 2016, 171 : 38 - 40
  • [44] A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3KS) syndrome (APDS): Adolescent and adult subgroup analysis
    Rao, V. Koneti
    Sediva, Anna
    Dalm, Virgil A. S. H.
    Plebani, Alessandro
    Schuetz, Catharina
    Shcherbina, Anna
    Trizzino, Antonino
    Zharankova, Yulia
    Orpia, Alanvin
    Kulm, Elaine
    Webster, Sharon
    Koerholz, Julia
    Lougaris, Vassilios
    Rodina, Yulia
    Conlon, Niall
    Coulter, Tanya
    Bradt, Jason
    Relan, Anurag
    Uzel, Gulbu
    CLINICAL IMMUNOLOGY, 2025, 270
  • [45] Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase δ syndrome 1
    Lu Jiang
    Xiaohan Hu
    Qiang Lin
    Ruyue Chen
    Yunyan Shen
    Yun Zhu
    Qinying Xu
    Xiaozhong Li
    Allergy, Asthma & Clinical Immunology, 19
  • [46] Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase δ syndrome 1
    Jiang, Lu
    Hu, Xiaohan
    Lin, Qiang
    Chen, Ruyue
    Shen, Yunyan
    Zhu, Yun
    Xu, Qinying
    Li, Xiaozhong
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):
  • [47] The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS)
    Fekrvand, Saba
    Delavari, Samaneh
    Chavoshzadeh, Zahra
    Sherkat, Roya
    Mahdaviani, Seyed Alireza
    Shabestari, Mahnaz Sadeghi
    Azizi, Gholamreza
    Arzanian, Mohammad Taghi
    Shamsian, Bibi Shahin
    Eskandarzadeh, Shabnam
    Eslami, Narges
    Rae, William
    Condino-Neto, Antonio
    Mohammadi, Javad
    Abolhassani, Hassan
    Yazdani, Reza
    Aghamohammadi, Asghar
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (03) : 644 - 659
  • [48] A novel monoallelic gain of function mutation in p110δ causing atypical activated phosphoinositide 3-kinase δ syndrome (APDS-1)
    Lougaris, Vassilios
    Baronio, Manuela
    Moratto, Daniele
    Tampella, Giacomo
    Gazzurelli, Luisa
    Facchetti, Mattia
    Martire, Baldassarre
    Cardinale, Fabio
    Lanzarotto, Francesco
    Bondioni, Maria Pia
    Villanacci, Vincenzo
    Grimbacher, Bodo
    Plebani, Alessandro
    CLINICAL IMMUNOLOGY, 2019, 200 : 31 - 34
  • [49] Transverse myelitis in a patient with activated phosphoinositide 3-kinase δ syndrome type 1
    Orf, Kate
    Abbas, Ahmed
    Abdel-Aziz, Khaled
    Burns, Siobhan O.
    CLINICAL IMMUNOLOGY, 2020, 219
  • [50] INTUSSCEPTION: A NOVEL PRESENTATION OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE-Δ (PI3KΔ) SYNDROME (APDS)
    Gold, M.
    Chan, D.
    Marchand, B.
    Dzeladini, L.
    King, J.
    Cheung, A.
    Quinn, P.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 28 - 29
12345